SRPT

SEC source: 0001209191-16-142780 · doc4.xml · derivative · entry 3

Howton David T · CIK 0001529297 · SVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 65,007

Underlying: Common Stock · 7,000 shares

Expires 2025-02-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person, on March 16, 2016, accordingly, the reporting person had no discretion with regards to the timing of the transaction.

SEC source: 0001209191-16-142780 · doc4.xml · nonDerivative · entry 2

Howton David T · CIK 0001529297 · SVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,453

F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person, on March 16, 2016, accordingly, the reporting person had no discretion with regards to the timing of the transaction.

SEC source: 0001209191-16-142780 · doc4.xml · nonDerivative · entry 1

Howton David T · CIK 0001529297 · SVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,453

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person, on March 16, 2016, accordingly, the reporting person had no discretion with regards to the timing of the transaction.

SEC source: 0001209191-16-143452 · doc4.xml · derivative · entry 3

Ruff Shamim · CIK 0001685986 · SVP, Regulatory Affairs & Qual

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,486

Underlying: Common Stock · 7,311 shares

Expires 2025-02-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person, on March 16, 2016, accordingly, the reporting person had no discretion with regards to the timing of the transaction.

SEC source: 0001209191-16-143452 · doc4.xml · nonDerivative · entry 2

Ruff Shamim · CIK 0001685986 · SVP, Regulatory Affairs & Qual

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,239

F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person, on March 16, 2016, accordingly, the reporting person had no discretion with regards to the timing of the transaction.

SEC source: 0001209191-16-143452 · doc4.xml · nonDerivative · entry 1

Ruff Shamim · CIK 0001685986 · SVP, Regulatory Affairs & Qual

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,550

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person, on March 16, 2016, accordingly, the reporting person had no discretion with regards to the timing of the transaction.

SEC source: 0001209191-16-142357 · doc4.xml · derivative · entry 9

Kaye Edward M. MD · CIK 0001522780 · Director · President, CEO & CMO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,405 shares

Expires 2022-04-24

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person, on March 16, 2016, accordingly, the reporting person had no discretion with regards to the timing of the transaction.

SEC source: 0001209191-16-142357 · doc4.xml · derivative · entry 8

Kaye Edward M. MD · CIK 0001522780 · Director · President, CEO & CMO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 947 shares

Expires 2022-04-24

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person, on March 16, 2016, accordingly, the reporting person had no discretion with regards to the timing of the transaction.

SEC source: 0001209191-16-142357 · doc4.xml · derivative · entry 7

Kaye Edward M. MD · CIK 0001522780 · Director · President, CEO & CMO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 80,358

Underlying: Common Stock · 13,000 shares

Expires 2012-06-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person, on March 16, 2016, accordingly, the reporting person had no discretion with regards to the timing of the transaction.

SEC source: 0001209191-16-142357 · doc4.xml · nonDerivative · entry 6

Kaye Edward M. MD · CIK 0001522780 · Director · President, CEO & CMO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 76,983

F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person, on March 16, 2016, accordingly, the reporting person had no discretion with regards to the timing of the transaction.

SEC source: 0001209191-16-142357 · doc4.xml · nonDerivative · entry 5

Kaye Edward M. MD · CIK 0001522780 · Director · President, CEO & CMO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 87,388

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person, on March 16, 2016, accordingly, the reporting person had no discretion with regards to the timing of the transaction.

SEC source: 0001209191-16-142357 · doc4.xml · nonDerivative · entry 4

Kaye Edward M. MD · CIK 0001522780 · Director · President, CEO & CMO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 76,983

F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person, on March 16, 2016, accordingly, the reporting person had no discretion with regards to the timing of the transaction.

SEC source: 0001209191-16-142357 · doc4.xml · nonDerivative · entry 3

Kaye Edward M. MD · CIK 0001522780 · Director · President, CEO & CMO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 77,930

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person, on March 16, 2016, accordingly, the reporting person had no discretion with regards to the timing of the transaction.

SEC source: 0001209191-16-142357 · doc4.xml · nonDerivative · entry 2

Kaye Edward M. MD · CIK 0001522780 · Director · President, CEO & CMO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 76,983

F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person, on March 16, 2016, accordingly, the reporting person had no discretion with regards to the timing of the transaction.

SEC source: 0001209191-16-142357 · doc4.xml · nonDerivative · entry 1

Kaye Edward M. MD · CIK 0001522780 · Director · President, CEO & CMO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 89,983

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person, on March 16, 2016, accordingly, the reporting person had no discretion with regards to the timing of the transaction.

SEC source: 0001209191-16-142353 · doc4.xml · nonDerivative · entry 2

Mahatme Sandesh · CIK 0001511034 · Senior Vice President, CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,532

F2 · shares: 19,125 RSAs vest upon the Company exceeding $80 million in total revenue reported in publicly released GAAP financials, in any fiscal quarter between grant date and June 30, 2018, with an additional 4,781 RSAs vesting during the same period if the total revenue reported in the publicly released GAAP financials exceeds $100 million. The Company will withhold the shares to satisfy the executive's tax obligation upon vesting.

SEC source: 0001209191-16-142353 · doc4.xml · nonDerivative · entry 1

Mahatme Sandesh · CIK 0001511034 · Senior Vice President, CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,626

F1 · shares: 100% of the Restricted Stock Award ("RSA") granted on September 19, 2016 vests six months from the date of grant. The Company will withhold the shares to satisfy the executive's tax obligation upon vesting.

SEC source: 0001209191-16-142359 · doc4.xml · derivative · entry 6

Aphale Jayant · CIK 0001574696 · VP, Technical Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 61,580

Underlying: Common Stock · 25,000 shares

Expires 2021-12-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-16-142359 · doc4.xml · derivative · entry 5

Aphale Jayant · CIK 0001574696 · VP, Technical Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,420

Underlying: Common Stock · 10,000 shares

Expires 2021-12-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person, on December 11, 2015, accordingly, the reporting person had no discretion with regards to the timing of the transaction.

SEC source: 0001209191-16-142359 · doc4.xml · nonDerivative · entry 4

Aphale Jayant · CIK 0001574696 · VP, Technical Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,490

F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person, on December 11, 2015, accordingly, the reporting person had no discretion with regards to the timing of the transaction.

SEC source: 0001209191-16-142359 · doc4.xml · nonDerivative · entry 3

Aphale Jayant · CIK 0001574696 · VP, Technical Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,490

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person, on December 11, 2015, accordingly, the reporting person had no discretion with regards to the timing of the transaction.

SEC source: 0001209191-16-142359 · doc4.xml · nonDerivative · entry 2

Aphale Jayant · CIK 0001574696 · VP, Technical Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,490

F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person, on December 11, 2015, accordingly, the reporting person had no discretion with regards to the timing of the transaction.

SEC source: 0001209191-16-142359 · doc4.xml · nonDerivative · entry 1

Aphale Jayant · CIK 0001574696 · VP, Technical Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,490

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person, on December 11, 2015, accordingly, the reporting person had no discretion with regards to the timing of the transaction.

SEC source: 0001209191-16-142355 · doc4.xml · derivative · entry 6

Howton David T · CIK 0001529297 · SVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 72,007

Underlying: Common Stock · 8,000 shares

Expires 2025-02-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person, on March 16, 2016, accordingly, the reporting person had no discretion with regards to the timing of the transaction.

SEC source: 0001209191-16-142355 · doc4.xml · nonDerivative · entry 5

Howton David T · CIK 0001529297 · SVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,453

F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person, on March 16, 2016, accordingly, the reporting person had no discretion with regards to the timing of the transaction.

SEC source: 0001209191-16-142355 · doc4.xml · nonDerivative · entry 4

Howton David T · CIK 0001529297 · SVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,757

F3 · shares: 15,300 RSAs vest upon the Company exceeding $80 million in total revenue reported in publicly released GAAP financials, in any fiscal quarter between grant date and June 30, 2018, with an additional 3,825 RSAs vesting during the same period if the total revenue reported in the publicly released GAAP financials exceeds $100 million. The Company will withhold the shares to satisfy the executive's tax obligation upon vesting.

SEC source: 0001209191-16-142355 · doc4.xml · nonDerivative · entry 3

Howton David T · CIK 0001529297 · SVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,632

F2 · shares: 100% of the Restricted Stock Award ("RSA") granted on September 19, 2016 vests six months from the date of grant. The Company will withhold the shares to satisfy the executive's tax obligation upon vesting.

SEC source: 0001209191-16-142355 · doc4.xml · nonDerivative · entry 2

Howton David T · CIK 0001529297 · SVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,168

F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person, on March 16, 2016, accordingly, the reporting person had no discretion with regards to the timing of the transaction.

SEC source: 0001209191-16-142355 · doc4.xml · nonDerivative · entry 1

Howton David T · CIK 0001529297 · SVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,168

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person, on March 16, 2016, accordingly, the reporting person had no discretion with regards to the timing of the transaction.

SEC source: 0001209191-16-141771 · doc4.xml · nonDerivative · entry 1

Kaye Edward M. MD · CIK 0001522780 · SVP Interim CEO & CMO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 76,983

F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person, on March 16, 2016, accordingly, the reporting person had no discretion with regards to the timing of the transaction.